The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Isepamicin     3-amino-N-[5-amino-4-[6- (aminomethyl)-3,4...

Synonyms: Isepamicina, Isepamicine, Isepamicinum, HAPA-B, SureCN152418, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of HAPA-gentamycin B


High impact information on HAPA-gentamycin B


Chemical compound and disease context of HAPA-gentamycin B


Biological context of HAPA-gentamycin B


Anatomical context of HAPA-gentamycin B


Associations of HAPA-gentamycin B with other chemical compounds


Gene context of HAPA-gentamycin B


Analytical, diagnostic and therapeutic context of HAPA-gentamycin B


  1. Temporal variation in nephrotoxicity of low doses of isepamicin in rats. Yoshiyama, Y., Grenier, L., Gourde, P., Simard, M., Lin, L., Morin, N.J., Bergeron, M.G., Labrecque, G., Beauchamp, D. Antimicrob. Agents Chemother. (1996) [Pubmed]
  2. Pharmacokinetics of isepamicin during continuous venovenous hemodiafiltration. Breilh, D., Allaouchiche, B., Jaumain, H., Boulétreau, P., Chassard, D., Malbec, I., Ducint, D., Saux, M.C. Antimicrob. Agents Chemother. (1999) [Pubmed]
  3. Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli. Fuentes, F., Izquierdo, J., Martín, M.M., Gomez-Lus, M.L., Prieto, J. Antimicrob. Agents Chemother. (1998) [Pubmed]
  4. Activity of isepamicin and selection of permeability mutants to beta-lactams during aminoglycoside therapy of experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransferase 6' modifying enzyme and a TEM-3 beta-lactamase. Mainardi, J.L., Zhou, X.Y., Goldstein, F., Mohler, J., Farinotti, R., Gutmann, L., Carbon, C. J. Infect. Dis. (1994) [Pubmed]
  5. Clinical pharmacokinetics and pharmacodynamics of isepamicin. Tod, M., Padoin, C., Petitjean, O. Clinical pharmacokinetics. (2000) [Pubmed]
  6. Multidrug-resistant Pseudomonas aeruginosa strain that caused an outbreak in a neurosurgery ward and its aac(6')-Iae gene cassette encoding a novel aminoglycoside acetyltransferase. Sekiguchi, J., Asagi, T., Miyoshi-Akiyama, T., Fujino, T., Kobayashi, I., Morita, K., Kikuchi, Y., Kuratsuji, T., Kirikae, T. Antimicrob. Agents Chemother. (2005) [Pubmed]
  7. Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin. Thornsberry, C., Barry, A.L., Jones, R.N., Baker, C.N., Badal, R.E., Packer, R.R. Antimicrob. Agents Chemother. (1980) [Pubmed]
  8. The administration regimen of isepamicin in patients with chronic respiratory tract infection. Hara, K., Koga, H., Kohno, S., Kobayashi, H., Soejima, R., Nasu, M., Saito, A., Shimizu, K., Konno, M. Chemotherapy. (1995) [Pubmed]
  9. Diffusion of isepamicin into cancellous and cortical bone tissue. Boselli, E., Breilh, D., Bel, J.C., Debon, R., Saux, M.C., Chassard, D., Allaouchiche, B. Journal of chemotherapy (Florence, Italy) (2002) [Pubmed]
  10. Antibiotic use in neonatal sepsis. Yurdakök, M. Turk. J. Pediatr. (1998) [Pubmed]
  11. Pharmacokinetics of isepamicin following a single administration by intravenous infusion or intramuscular injections. Radwanski, E., Batra, V., Cayen, M., Korduba, C., Cutler, D., Affrime, M., Nomeir, A., Lin, C.C. Antimicrob. Agents Chemother. (1997) [Pubmed]
  12. Solution studies of isepamicin and conformational comparisons between isepamicin and butirosin A when bound to an aminoglycoside 6'-N-acetyltransferase determined by NMR spectroscopy. DiGiammarino, E.L., Draker, K.A., Wright, G.D., Serpersu, E.H. Biochemistry (1998) [Pubmed]
  13. Pharmacokinetics and metabolism of 14C-isepamicin in humans following intravenous administration. Lin, C., Korduba, C., Affrime, M., Radwanski, E., Nomeir, A., Batra, V., Cutler, D., Cayen, M.N. Antimicrob. Agents Chemother. (1995) [Pubmed]
  14. Isepamicin (SCH 21420, 1-N-HAPA gentamicin B): microbiological characteristics including antimicrobial potency of spectrum of activity. Jones, R.N. Journal of chemotherapy (Florence, Italy) (1995) [Pubmed]
  15. Effect of isepamicin dosing scheme on concentration in cochlear tissue. Govaerts, P.J., Claes, J., Van de Heyning, P.H., Derde, M.P., Kaufman, L., Marquet, J.F., De Broe, M.E. Antimicrob. Agents Chemother. (1991) [Pubmed]
  16. Column liquid chromatographic determination of isepamicin in nasal cavity using gauze. Shoshihara, M., Kase, K., Yoshizawa, E., Takao, M., Fujimoto, T. J. Chromatogr. (1990) [Pubmed]
  17. Resistance to amikacin and isepamicin in rabbits with experimental endocarditis of an aac(6')-Ib-bearing strain of Klebsiella pneumoniae susceptible in vitro. Caulin, E., Coutrot, A., Carbon, C., Collatz, E. Antimicrob. Agents Chemother. (1996) [Pubmed]
  18. In vitro activity of Sch 21420, derivative of gentamicin B, compared to that of amikacin. Kabins, S.A., Nathan, C. Antimicrob. Agents Chemother. (1978) [Pubmed]
  19. In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan. Cheng, N.C., Hsueh, P.R., Liu, Y.C., Shyr, J.M., Huang, W.K., Teng, L.J., Liu, C.Y. Microb. Drug Resist. (2005) [Pubmed]
  20. Rabbits treated with chronic isepamicin are resistant to mivacurium and rocuronium. Kim, K.S., Shim, J.C., Jun, J.H., Lee, K.H., Chung, C.W. Anesth. Analg. (1999) [Pubmed]
  21. Effects of some antibiotics on activity of glucose-6-phosphate dehydrogenase from human erythrocytes in vitro and effect of isepamicin sulfate on activities of antioxidant enzymes in rat erythrocytes. Ozmen, I., Küfrevioğlu, O.I., Gul, M. Drug and chemical toxicology. (2005) [Pubmed]
  22. Isepamicin disposition in subjects with various degrees of renal function. Halstenson, C.E., Kelloway, J.S., Affrime, M.B., Lin, C.C., Teal, M.A., Shapiro, B.E., Awni, W.M. Antimicrob. Agents Chemother. (1991) [Pubmed]
  23. Population pharmacokinetic study of isepamicin with intensive care unit patients. Tod, M., Padoin, C., Minozzi, C., Cougnard, J., Petitjean, O. Antimicrob. Agents Chemother. (1996) [Pubmed]
  24. Pharmacokinetics of intravenously administered isepamicin in men. Lin, C.C., Radwanski, E., Korduba, C., Cayen, M., Affrime, M. Antimicrob. Agents Chemother. (1995) [Pubmed]
WikiGenes - Universities